Oklo 10-Qquarter ended 2026-09-30

Executive Summary

Oklo develops nuclear powerhouses to sell electricity and heat to data centers and other large users; current revenue comes mainly from acquired engineering businesses. It plans to own and operate its Aurora powerhouses, targeting first deployment in 2028–2029 rather than licensing reactor designs. Safety approvals, fuel arrangements and customer-development agreements advanced, but commercial power generation remains unproven. Equity-funded liquidity reached $3.13B, giving Oklo resources to build; investors still face substantial licensing, construction and customer-conversion risk before recurring power revenue begins.

What's Happening in the Business

Aurora-ID in Idaho moved through important regulatory milestones. The Department of Energy approved its preliminary safety analysis in June, following Nuclear Regulatory Commission approval of principal design criteria in April. The safety analysis represents two of five steps in the Department of Energy operating pathway—not permission to operate. Initial projects are expected to cost more and take longer than subsequent standardized deployments.

Customer interest is substantial but differs sharply from contracted revenue. Switch’s Master Power Agreement covers 12 gigawatts, while Equinix, Diamondback Energy and Prometheus Hyperscale have nonbinding letters of intent. Meta’s prepayment agreement supports a planned 1.2-gigawatt Ohio campus; on 11/02/2026, an initial escrow payment was released directly to Centrus toward fuel orders. Binding power contracts, fuel availability and grid access remain necessary to turn these arrangements into operating projects.

Oklo is also building internal capabilities. June acquisitions of ARMEC and Creative Engineers added machining, prototyping and chemical-process expertise while generating service revenue from existing customers. Fuel-fabrication safety documents advanced, but a prospective domestic fuel-supply agreement targeting deliveries from 2029 remained under negotiation. The Tennessee Advanced Fuel Center’s investment roadmap reaches up to $1.68B, underscoring the capital required beyond individual powerhouses.

Radioisotopes offer a potentially earlier revenue stream. The Groves test reactor achieved first criticality on 08/05/2026, validating a development step rather than commercial production capacity. Management expects Abundantia revenue in 2027, subject to material-handling permits.

Key Financial Highlights

• Development and overhead: Q3 R&D reached $41.6M, +179% Y/Y; general and administrative expense reached $41.6M, +95%. Payroll, stock-based compensation and professional services drove both; management expects overhead to rise further.
• Earnings offsets: Q3 interest and dividend income was $27.9M vs $7.12M. Selling land produced a one-time $11.4M operating gain, which is not recurring business improvement.
• Cash use: 9M OCF was $(111)M vs $(48.7)M, against the same-period net loss above. Noncash stock-based compensation of $49.1M helped make cash outflow smaller than the accounting loss; interest receipts also supported cash. Capital expenditures reached $281M vs $6.26M.
• Funding and dilution: Cash, equivalents and marketable debt securities increased 122% from year-end. Share sales generated $2.25B net; outstanding shares rose 22% to 195M. Equity funding strengthened liquidity while reducing existing holders’ ownership percentage.

Risk Assessment

• Licensing and execution: Aurora has not demonstrated commercial operation, and remaining approvals, first-of-a-kind construction and fuel constraints could delay deployment or undermine project economics.
• Customer conversion: AI customers may change capacity requirements or secure alternative power before Aurora becomes available; preliminary arrangements do not establish financeable demand.
• Grid access: Federal regulators rejected Oklo’s challenge to withdrawal of a Virginia interconnection request, separate from Ohio; nuclear approvals alone cannot secure transmission capacity or prevent costly delays.
• Capital intensity and dilution: Owning powerhouses while developing fuel and isotope facilities requires substantial continuing investment, potentially exceeding current resources and requiring further share issuance.

This 10-Q lists only the risk factors that changed since the annual report. Full list: FY2025 10-K.

What to Watch

• Aurora-ID execution: First deployment remains management’s 2028–2029 target. Remaining approvals and construction progress would support that timetable; redesigns or schedule extensions would weaken it.
• Customer commitments: Watch whether Switch and Meta development arrangements progress into binding power contracts and executable sites. Contract delays, reduced capacity or interconnection setbacks would challenge the demand thesis.
• Isotope commercialization: Abundantia targets revenue in 2027, conditional on permits. Permitted sales would establish an earlier commercial foothold; delays would leave revenue dependent on acquired services.
• Spending trajectory: Management expects 2026 operating cash use of $120–$150M and capital expenditures of $400–$500M. Spending accompanied by deployment milestones would demonstrate progress; escalating outlays without them would erode the funding cushion.